BARDA awards Emergent 10-year, $704M contract for Ebola treatment
Emergent BioSolutions has landed a $704 million contract from BARDA.
The manufacturer announced the BARDA award on Tuesday for a 10-year contract to develop and …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.